Literature DB >> 11896393

Dynamic visualization of a joint-specific autoimmune response through positron emission tomography.

Brian T Wipke1, Zheng Wang, Joonyoung Kim, Timothy J McCarthy, Paul M Allen.   

Abstract

In the K/BxN mouse model of rheumatoid arthritis, the transfer of autoantibodies specific for glucose-6-phosphate isomerase (GPI) into naïve mice rapidly induces joint-specific inflammation similar to that seen in human rheumatoid arthritis. The ubiquitous expression of GPI and the systemic circulation of anti-GPI immunoglobulin G (IgG) seem incongruous with the tissue specificity of this disease. By using PET (positron emission tomography), we show here that purified anti-GPI IgG localizes specifically to distal joints in the front and rear limbs within minutes of intravenous injection, reaches saturation by 20 min and remains localized for at least 24 h. In contrast, control IgG does not localize to joints or cause inflammation. The rapid kinetics of anti-GPI IgG joint localization supports a model in which autoantibodies bind directly to pre-existing extracellular GPI in normal healthy mouse joints.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896393     DOI: 10.1038/ni775

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  42 in total

1.  Ly6G ligation blocks recruitment of neutrophils via a β2-integrin-dependent mechanism.

Authors:  Jun-Xia Wang; Angela M Bair; Sandra L King; Ruslan Shnayder; Ya-Fang Huang; Chi-Chang Shieh; Roy J Soberman; Robert C Fuhlbrigge; Peter A Nigrovic
Journal:  Blood       Date:  2012-06-01       Impact factor: 22.113

Review 2.  Ligand-dependent regulation of T cell development and activation.

Authors:  Ronald N Germain
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 3.  [Molecular imaging: future uses in arthritides].

Authors:  M H Brem; P M Schlechtweg; J Mackenzie; C S Winalski; P Lang
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

Review 4.  Why location matters - site-specific factors in rheumatic diseases.

Authors:  Caroline Ospelt; Mojca Frank-Bertoncelj
Journal:  Nat Rev Rheumatol       Date:  2017-06-15       Impact factor: 20.543

5.  Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1.

Authors:  Peter A Nigrovic; Bryce A Binstadt; Paul A Monach; Alyssa Johnsen; Michael Gurish; Yoichiro Iwakura; Christophe Benoist; Diane Mathis; David M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-02       Impact factor: 11.205

6.  PET assessment of disease activity in children with juvenile idiopathic arthritis.

Authors:  Ukihide Tateishi; Tomoyuki Imagawa; Noriko Kanezawa; Tetsuhiko Okabe; Kazuya Shizukuishi; Tomio Inoue; Shumpei Yokota
Journal:  Pediatr Radiol       Date:  2010-06-04

Review 7.  Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis.

Authors:  Laura Mandik-Nayak; Paul M Allen
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis.

Authors:  F Jouen; O Vittecoq; F Leguillou; I Tabti-Titon; J F Menard; O Mejjad; S Pouplin; P Boumier; P Fardellone; A Gayet; D Gilbert; F Tron; X Le Loët
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Detection of Subclinical Arthritis in Mice by a Thrombin Receptor-Derived Imaging Agent.

Authors:  Beth Friedman; Michael A Whitney; Elamprakash N Savariar; Christa Caneda; Paul Steinbach; Qing Xiong; Dina V Hingorani; Jessica Crisp; Stephen R Adams; Michael Kenner; Csilla N Lippert; Quyen T Nguyen; Monica Guma; Roger Y Tsien; Maripat Corr
Journal:  Arthritis Rheumatol       Date:  2017-11-29       Impact factor: 10.995

10.  Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice.

Authors:  Lisa Bruns; Oliver Frey; Lars Morawietz; Christiane Landgraf; Rudolf Volkmer; Thomas Kamradt
Journal:  Arthritis Res Ther       Date:  2009-07-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.